Gastroprotective effect of cirsilineol against hydrochloric acid/ethanol-induced gastric ulcer in rats.

Antioxidant Inflammation Phenolic Stomach ulcer

Journal

The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
ISSN: 1226-4512
Titre abrégé: Korean J Physiol Pharmacol
Pays: Korea (South)
ID NLM: 9709505

Informations de publication

Date de publication:
01 Sep 2021
Historique:
received: 05 01 2021
revised: 08 06 2021
accepted: 08 06 2021
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 28 8 2021
Statut: ppublish

Résumé

This study was designed to evaluate the gastroprotective activity of cirsilineol in hydrochloric acid (HCl)/ethanol-induced gastric ulcer model. Cirsilineol was administered at the doses of 20 and 40 mg/kg in HCl/ethanol-induced rats. The gastroprotective ability was verified by determining the ulcer score, total acidity, hemoglobin, inflammatory cytokines, lipid peroxides, and enzymatic antioxidants superoxide dismutase (SOD) and catalase (CAT) in gastric tissue and serum biochemical analysis. The results showed a favorable increase in the hemoglobin level, antioxidant enzymes (SOD and CAT), restored electrochemical balance (carbon dioxide & anion gap) while a noticeable decrease in ulcer index, total acidity, lipid peroxides, inflammatory cytokines (interleukin-1 beta [IL-1β], IL-6, and tumor necrosis factor alpha) in rats treated with the cirsilineol. The serum biochemical analysis on liver markers (alkaline phosphatases, alanine aminotransferase, and aspartate aminotransferase), kidney markers (urea, creatinine, albumin, globulin, total protein), and lipid profile (triglyceride, high-density lipoprotein, total cholesterol) were attenuated by cirsilineol treatment in rats. Histopathology showed enhanced gastric protection and preserved the integrity of gastric mucosa upon cirsilineol administration. These results ultimately suggest that cirsilineol has gastroprotective effects that prevent the development of gastric ulcer.

Identifiants

pubmed: 34448458
pii: kjpp.2021.25.5.403
doi: 10.4196/kjpp.2021.25.5.403
pmc: PMC8405436
doi:

Types de publication

Journal Article

Langues

eng

Pagination

403-411

Références

Chem Biol Interact. 2015 Mar 5;229:26-35
pubmed: 25637687
Lancet. 2009 Oct 24;374(9699):1449-61
pubmed: 19683340
J Ethnopharmacol. 2015 Dec 4;175:75-85
pubmed: 26364940
Dig Dis Sci. 2009 Apr;54(4):725-30
pubmed: 18688716
Nat Prod Bioprospect. 2014 Apr;4(2):81-9
pubmed: 24858035
Molecules. 2018 Jul 17;23(7):
pubmed: 30018251
Gastrointest Endosc Clin N Am. 2011 Oct;21(4):613-35
pubmed: 21944414
PLoS One. 2015 Mar 30;10(3):e0122417
pubmed: 25821971
Life Sci. 2017 Nov 15;189:44-51
pubmed: 28919395
J Pineal Res. 2007 Aug;43(1):56-64
pubmed: 17614836
Eur J Pharmacol. 2015 Mar 5;750:167-75
pubmed: 25617794
Drug Des Devel Ther. 2017 Mar 30;11:995-1009
pubmed: 28408799
Drug Des Devel Ther. 2016 Jan 13;10:297-313
pubmed: 26834460
Gastroenterol Rep (Oxf). 2015 Aug;3(3):201-8
pubmed: 25698559
Eur J Biochem. 1974 Sep 16;47(3):469-74
pubmed: 4215654
Biomed Pharmacother. 2020 Jun;126:110075
pubmed: 32179202
World J Gastrointest Pathophysiol. 2014 Feb 15;5(1):40-7
pubmed: 24891974
Pharmacoepidemiol Drug Saf. 2011 Jul;20(7):718-28
pubmed: 21626606
Indian J Exp Biol. 2002 Jan;40(1):58-62
pubmed: 12561970
Asian Pac J Trop Med. 2011 Apr;4(4):278-82
pubmed: 21771470
Int Immunopharmacol. 2013 Jun;16(2):296-305
pubmed: 23602913
J Tradit Complement Med. 2018 Sep 28;9(4):372-382
pubmed: 31453134
Indian J Pharm Sci. 2011 Sep;73(5):550-7
pubmed: 22923868
J Tradit Chin Med. 2015 Dec;35(6):666-70
pubmed: 26742312
Pharm Biol. 2017 Dec;55(1):218-226
pubmed: 27927061

Auteurs

Guojin Gong (G)

Department of Gastrointestinal Surgery, Xichang People's Hospital, Xichang 615000, China.

Rigetu Zhao (R)

Department of Gastroenterology, The Affiliated Hospital of Inner Mongolia University for Nationalities, Tongliao 028000, China.

Yuhui Zhu (Y)

Department of Pharmacy, The Second Hospital of Jilin University, Changchun 130041, China.

Jinfeng Yu (J)

General Medicine Yantaishan Hospital, Yantai 264001, China.

Bin Wei (B)

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China.

Yan Xu (Y)

Chongqing University Affiliated Tumor Hospital/Chongqing Cancer Institute, Chongqing 400030, China.

Zhaoxun Cui (Z)

Department of Oncology, Shaanxi Forest Industry Hospital, Xi'an 710000, China.

Guoying Liang (G)

Department of Liver, Spleen and Stomach Diseases, First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Heilongjiang 150040, China.

Classifications MeSH